SE0400501D0 - Antibody purification - Google Patents

Antibody purification

Info

Publication number
SE0400501D0
SE0400501D0 SE0400501A SE0400501A SE0400501D0 SE 0400501 D0 SE0400501 D0 SE 0400501D0 SE 0400501 A SE0400501 A SE 0400501A SE 0400501 A SE0400501 A SE 0400501A SE 0400501 D0 SE0400501 D0 SE 0400501D0
Authority
SE
Sweden
Prior art keywords
cation
aromatic
solution
modal
exchanging group
Prior art date
Application number
SE0400501A
Other languages
English (en)
Swedish (sv)
Inventor
Bo-Lennart Johansson
Hans J Johansson
Anders Ljungloef
Jean-Luc Maloisel
Nicolas Thevenin
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Priority to SE0400501A priority Critical patent/SE0400501D0/xx
Publication of SE0400501D0 publication Critical patent/SE0400501D0/xx
Priority to EP05722174A priority patent/EP1718668B1/de
Priority to CN2005800062670A priority patent/CN1926146B/zh
Priority to CA2552823A priority patent/CA2552823C/en
Priority to AU2005217348A priority patent/AU2005217348B2/en
Priority to AT05722174T priority patent/ATE440858T1/de
Priority to US10/589,718 priority patent/US7385040B2/en
Priority to NZ548127A priority patent/NZ548127A/en
Priority to DE602005016220T priority patent/DE602005016220D1/de
Priority to JP2007500724A priority patent/JP4776615B2/ja
Priority to PCT/SE2005/000292 priority patent/WO2005082926A1/en
Priority to KR1020067017115A priority patent/KR101149969B1/ko
Priority to KR1020067017113A priority patent/KR101150050B1/ko
Priority to CA2552639A priority patent/CA2552639C/en
Priority to EP05722175A priority patent/EP1718386A1/de
Priority to JP2007500725A priority patent/JP4848356B2/ja
Priority to CN200580006276XA priority patent/CN1925898B/zh
Priority to NZ548126A priority patent/NZ548126A/en
Priority to US10/589,717 priority patent/US7750129B2/en
Priority to PCT/SE2005/000293 priority patent/WO2005082483A1/en
Priority to AU2005216847A priority patent/AU2005216847B2/en
Priority to IL176635A priority patent/IL176635A/en
Priority to IL176745A priority patent/IL176745A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B01J39/07—Processes using organic exchangers in the weakly acidic form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE0400501A 2004-02-27 2004-02-27 Antibody purification SE0400501D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification
KR1020067017115A KR101149969B1 (ko) 2004-02-27 2005-02-24 항체 정제
PCT/SE2005/000292 WO2005082926A1 (en) 2004-02-27 2005-02-24 Antibody purification
CN2005800062670A CN1926146B (zh) 2004-02-27 2005-02-24 抗体纯化
CA2552823A CA2552823C (en) 2004-02-27 2005-02-24 Antibody purification
AU2005217348A AU2005217348B2 (en) 2004-02-27 2005-02-24 Antibody purification
AT05722174T ATE440858T1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikírpern
US10/589,718 US7385040B2 (en) 2004-02-27 2005-02-24 Antibody purification
NZ548127A NZ548127A (en) 2004-02-27 2005-02-24 Method for antibody purification
DE602005016220T DE602005016220D1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikörpern
JP2007500724A JP4776615B2 (ja) 2004-02-27 2005-02-24 抗体精製
EP05722174A EP1718668B1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikörpern
AU2005216847A AU2005216847B2 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
KR1020067017113A KR101150050B1 (ko) 2004-02-27 2005-02-25 항체 정제 방법
CA2552639A CA2552639C (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
EP05722175A EP1718386A1 (de) 2004-02-27 2005-02-25 Verfahren zur reinigung von antikörpern
JP2007500725A JP4848356B2 (ja) 2004-02-27 2005-02-25 抗体精製法
CN200580006276XA CN1925898B (zh) 2004-02-27 2005-02-25 纯化抗体的工艺
NZ548126A NZ548126A (en) 2004-02-27 2005-02-25 A process for the purification of antibodies involving addition of a second resin
US10/589,717 US7750129B2 (en) 2004-02-27 2005-02-25 Process for the purification of antibodies
PCT/SE2005/000293 WO2005082483A1 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
IL176635A IL176635A (en) 2004-02-27 2006-06-29 Method of purification of antibodies from one or more contaminants by chromatography and a system for such purification
IL176745A IL176745A (en) 2004-02-27 2006-07-06 Process for the purification of antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Publications (1)

Publication Number Publication Date
SE0400501D0 true SE0400501D0 (sv) 2004-02-27

Family

ID=32067281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Country Status (13)

Country Link
US (1) US7385040B2 (de)
EP (1) EP1718668B1 (de)
JP (1) JP4776615B2 (de)
KR (1) KR101149969B1 (de)
CN (2) CN1926146B (de)
AT (1) ATE440858T1 (de)
AU (1) AU2005217348B2 (de)
CA (1) CA2552823C (de)
DE (1) DE602005016220D1 (de)
IL (1) IL176635A (de)
NZ (1) NZ548127A (de)
SE (1) SE0400501D0 (de)
WO (1) WO2005082926A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
US7589183B2 (en) * 2006-11-28 2009-09-15 Bio-Rad Laboratories, Inc. Prevention of leaching of ligands from affinity-based purification systems
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
WO2008085116A1 (en) * 2007-01-10 2008-07-17 Ge Healthcare Bio-Sciences Ab Mult i -modal ion exchange chromotography resins
EP2139573B1 (de) 2007-03-28 2016-11-09 DPx Holdings B.V. Expanded-bed-säule und einmal-chromatographie
CN101679509A (zh) * 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
EP2027875A1 (de) * 2007-08-23 2009-02-25 Octapharma AG Verfahren zur Isolierung und Reinigung eines prionenproteinfreien Target-Proteins
WO2009054226A1 (ja) * 2007-10-26 2009-04-30 Asahi Kasei Chemicals Corporation たんぱく質の精製方法
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
US8753868B2 (en) 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
US20100051554A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Molecular basket coated micro particles
JPWO2010071208A1 (ja) * 2008-12-19 2012-05-31 武田薬品工業株式会社 抗体の精製方法
CN101797493B (zh) * 2009-02-06 2014-05-21 上海抗体药物国家工程研究中心有限公司 一种在反应釜中制备亲和层析介质的方法
DE102009057993A1 (de) 2009-06-13 2011-01-20 Sartorius Stedim Biotech Gmbh Polysaccharidmatrix mit aufgepfropftem Polymer, Verfahren zu ihrer Herstellung und Verwendung
JPWO2011001963A1 (ja) * 2009-07-03 2012-12-13 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
EP2490780A4 (de) * 2009-10-20 2014-04-09 Merck Sharp & Dohme Verwendung einer mischmodus-chromatographie zur erfassung und reinigung basischer antikörperprodukte
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
EP2519536A4 (de) * 2009-12-29 2013-06-05 Reddys Lab Ltd Dr Proteinreinigung durch ionenaustausch
KR101152036B1 (ko) 2010-04-27 2012-06-08 (주)셀트리온 컬럼 순환 및 시료 연속주입법을 이용한 단백질 ａ 크로마토그래피 정제 방법
KR101619865B1 (ko) 2010-07-30 2016-05-11 이엠디 밀리포어 코포레이션 크로마토그래피 매질
SG10201605397PA (en) 2011-07-01 2016-08-30 Hoffmann La Roche Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides
US20130109807A1 (en) * 2011-10-26 2013-05-02 Bio-Rad Laboratories, Inc. Removal of virucidal agents in mixed mode chromatography
GB201202762D0 (en) 2012-02-17 2012-04-04 Autology Health Ltd High efficiency cell capture
CN103506079B (zh) * 2012-06-19 2016-04-06 汪志友 一种用于分离纯化抗体的介质及其制备方法
US9890191B2 (en) 2012-09-03 2018-02-13 Kaneka Corporation Mixed-mode antibody affinity separation matrix and purification method using the same, and the target molecules
EP2812091B1 (de) 2012-09-17 2021-03-10 W.R. Grace & CO. - CONN. Chromatographiemedien und -vorrichtungen
EP2919902B1 (de) 2012-11-13 2020-01-01 GE Healthcare BioProcess R&D AB Multimodale anionenaustauschmatrizen
WO2014134147A1 (en) 2013-02-26 2014-09-04 Natrix Separations Inc. Mixed-mode chromatography membranes
TWI596107B (zh) 2013-06-25 2017-08-21 卡地拉保健有限公司 單株抗體之新穎純化方法
JPWO2015041218A1 (ja) 2013-09-17 2017-03-02 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎＭｅｔｈｏｄａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体（ＮｏｖｅｌＡｎｔｉｂｏｄｙＰｕｒｉｆｉｃａｔｉｏｎｍｅｔｈｏｄｕｓｉｎｇＣａｔｉｏｎＥｘｃｈａｎｇｅｒａｎｄＡｎｔｉｂｏｄｙｏｂｔａｉｎｅｄｔｈｅｒｅｆｒｏｍ）
WO2015071913A1 (en) * 2013-11-17 2015-05-21 New Proteintech Inc. Method of preparing chromatographic materials
ES2887110T3 (es) 2014-01-16 2021-12-21 Grace W R & Co Medios para cromatografía de afinidad y dispositivos para cromatografía
CN106103478B (zh) 2014-03-21 2020-04-03 豪夫迈·罗氏有限公司 抗体体内半寿期的体外预测
PL3137209T3 (pl) 2014-05-02 2023-01-02 W.R. Grace & Co. - Conn. Funkcjonalizowany materiał nośnikowy i sposoby wytwarzania oraz stosowania funkcjonalizowanego materiału nośnikowego
DE102014010353B4 (de) 2014-07-10 2024-09-12 Sartorius Stedim Biotech Gmbh Vorrichtung, Verwendung dieser Vorrichtung und Verfahren für die Stofftrennung mit verbesserter Ausnutzung der Kapazität chromatographischer Medien
EP3173783B1 (de) 2014-07-25 2019-02-27 Asahi Kasei Medical Co., Ltd. Träger zur kationenaustauschchromatographie und verfahren zur verwendung davon
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
DK3215528T3 (da) 2014-11-06 2019-10-07 Hoffmann La Roche Fc-regionvarianter med modificeret FcRn-binding og anvendelsesfremgangsmåder
EP3230299A1 (de) 2014-12-08 2017-10-18 EMD Millipore Corporation Mischbettionenaustauschadsorber
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
JP2019070528A (ja) * 2016-02-26 2019-05-09 Jsr株式会社 多孔質担体、アフィニティクロマトグラフィー用多孔質担体、標的物の精製方法、及び抗体
JP6846434B2 (ja) * 2016-04-29 2021-03-24 クレオプティクス・アーゲーＣｒｅｏｐｔｉｘ Ａｇ 分子を回収するための方法およびアセンブリ
US11020686B2 (en) 2016-08-16 2021-06-01 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
JP7102401B2 (ja) 2016-10-25 2022-07-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド クロマトグラフィーデータ解析のための方法およびシステム
US10799597B2 (en) 2017-04-03 2020-10-13 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CA3073935A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals, Inc. Methods of reducing particle formation and compositions formed thereby
US12343702B2 (en) 2018-03-08 2025-07-01 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
WO2020004583A1 (ja) * 2018-06-29 2020-01-02 三菱ケミカル株式会社 ポリペプチドの分離方法、ポリペプチドの製造方法及びポリペプチドの精製装置
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
WO2021046284A1 (en) 2019-09-05 2021-03-11 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462046C (sv) 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4983722A (en) * 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
US6498236B1 (en) * 1996-08-30 2002-12-24 Upfront Chromatography A/S Isolation of immunoglobulins
SE0002688D0 (sv) * 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
WO2002053288A2 (en) * 2000-12-31 2002-07-11 Amersham Biosciences Ab A method for the manufacture of compositions containing low concentrations of salts
JP2004517310A (ja) * 2001-01-05 2004-06-10 プロ・ケム インク 精製器具及び方法
SE0103084D0 (sv) 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
CA2473144C (en) 2002-02-05 2013-05-28 Genentech, Inc. Protein purification
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography

Also Published As

Publication number Publication date
ATE440858T1 (de) 2009-09-15
CN1926146A (zh) 2007-03-07
JP4776615B2 (ja) 2011-09-21
US7385040B2 (en) 2008-06-10
CN1925898A (zh) 2007-03-07
CN1925898B (zh) 2010-09-01
EP1718668B1 (de) 2009-08-26
IL176635A0 (en) 2006-10-31
WO2005082926A1 (en) 2005-09-09
CA2552823A1 (en) 2005-09-09
EP1718668A1 (de) 2006-11-08
NZ548127A (en) 2009-09-25
CN1926146B (zh) 2010-06-16
AU2005217348B2 (en) 2011-03-31
CA2552823C (en) 2013-11-19
KR20070001969A (ko) 2007-01-04
JP2008505851A (ja) 2008-02-28
IL176635A (en) 2011-07-31
US20070112178A1 (en) 2007-05-17
KR101149969B1 (ko) 2012-07-05
AU2005217348A1 (en) 2005-09-09
DE602005016220D1 (de) 2009-10-08

Similar Documents

Publication Publication Date Title
SE0400501D0 (sv) Antibody purification
WO2006138737A8 (en) Methods of purifying anti a beta antibodies
EA200970230A1 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
ATE425989T1 (de) Proteinreinigungsverfahren
WO2004024866A3 (en) Protein purification
EA200702210A1 (ru) Способ очистки белков
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
EP1568710A3 (de) Reinigungsmethode für Antikörper
WO2008087184A3 (en) Process for the purification of fc-containing proteins
WO2002088306A3 (en) Humanized antibodies
WO2003066662A3 (en) Protein purification
ATE409047T1 (de) Humanisierte antikörper
EA200970231A1 (ru) СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ
DK1689777T3 (da) Fremgangsmåde til oprensning af il18-bindende protein
Kish et al. Peptide-based affinity adsorbents with high binding capacity for the purification of monoclonal antibodies
SE0300791D0 (sv) Use of ph-responsive polymers
FR2892820B1 (fr) Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin
ATE417056T1 (de) Verfahren zur proteinreinigung
DE602006020333D1 (de) Multimere fc-rezeptor-polypeptide
Gallant Immunoaffinity chromatography of proteins
JP5067917B2 (ja) Ａｄａｍｔｓ１３の分離精製方法
Jain et al. An integrated process for separation of major and minor proteins from goat serum
EP2129461A4 (de) Reinigung von immunoglobulinen
ATE468343T1 (de) Verfahren zur reinigung von tacrolimus